Ra Pharmaceuticals Inc buy stratec
Start price
20.07.18
/
50%
€9.86
Target price
03.04.20
€51.65
Performance (%)
344.27%
End price
03.04.20
-
Summary
This prediction ended on 03.04.20 with a price of -. With a performance of 344.27% the BUY prediction by stratec was a big success. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ra Pharmaceuticals Inc | 3.256% | 3.256% | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by stratec for this prediction
In the thread Ra Pharmaceuticals Inc diskutieren
stratec stimmt dem Sentiment von 'Buy' zu
- Ra Pharmaceuticals (NASDAQ:RARX) initiated with Outperform rating and $20 (82% upside) price target at BMO.
Kursziel geändert auf 51,648